ArticleMolecular neurobiology2025
Nitrosative Stress Mediates Disruption of Redox Homeostasis and Oxidative Phosphorylation Caused by 3-Hydroxyisobutyric Acid in Cerebral Cortex of Developing Rats.
Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Adverse Effects of Carbon Black Nanoparticles on Maternal and Fetal Lungs in Pregnant Mice: Insights From a Metabolomics Perspective.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
3-Hydroxyisobutyric acid dehydrogenase (HIBADH) deficiency is biochemically characterized by tissue accumulation of L-3-hydroxyisobutyric acid (3HIBA). Some patients manifest neurologic symptoms and cerebral magnetic resonance imaging abnormalities whose pathophysiology is unknown. We evaluated the in vitro and in vivo effects of 3HIBA on important parameters of redox homeostasis and oxidative phosphorylation in cerebral cortex of developing rats. The in vitro studies revealed that 3HIBA significantly increased nitrite and nitrate levels and decreased reduced glutathione concentrations (GSH), glutathione peroxidase (GPx) and glutathione reductase activities (GR). 3HIBA also inhibited the activities of complex IV and moderately complex II-III of the respiratory chain, as well as ATP production. Noteworthy, the nitric oxide synthase inhibitor L-N-Nitro-L-arginine methyl ester prevented the augmented levels of nitrate and nitrite, the inhibition of GPx and complex IV activities, and the reduction of GSH and ATP levels caused by 3HIBA, supporting an important role of nitrosative stress in the disruption of redox homeostasis and oxidative phosphorylation. These biochemical markers were not altered by 3-hydroxybutyric acid, the isomer of 3HIBA, indicating a selective property of 3HIBA. Furthermore, intracerebroventricular administration of 3HIBA induced augmented cortical levels of nitrite and nitrate and decreased of GSH concentrations, GPx and complex IV activities. It also increased the mRNA expression of the antioxidant enzymes GPx1, SOD2 and GR, as well as of the oxidative stress modulator NRF2 and of the enzyme iNOS. The present data provide novel evidence of 3HIBA neurotoxicity, bringing new insights on the role of this organic acid in HIBADH deficiency neuropathology.
Indexed as
Identifiers
41422170What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.